Topical Finasteride Therapy in Hirsutism

    January 2001 in “ Endocrine Practice
    Luis J. Rodriguez-Rigau
    Image of study
    TLDR Topical finasteride may help treat facial hirsutism in women.
    The article discusses a small study that suggests that topical finasteride treatment may be beneficial for facial hirsutism in women. Hirsutism is a common problem in women, and most hirsute women are found to have abnormally high circulating androgen levels. Treatment for hirsutism necessitates a thorough medical history and physical examination as well as laboratory testing to ascertain the pathogenesis of the disorder. Antiandrogens have been prescribed for more than 3 decades in the treatment of hirsutism. The primary action of these agents is competition with androgens for their receptor. In many countries, cyproterone acetate (CPA) is the most commonly used medication in hirsutism. This drug is not available in the United States. CPA is an antiandrogen with substantial progestational activity, and it is generally used in combination with an estrogen as an oral contraceptive. Although CPA has been shown to have beneficial effects in patients with hirsutism, it has not been found to be more effective or to have fewer side effects than other antiandrogens. In the United States, the aldosterone antagonist spironolactone is the most commonly used antiandrogen in the treatment of hirsutism. It competitively inhibits the interaction of dihydrotestosterone with its receptor. It also has some effect in reduction of synthesis of androgen through inhibition of 17-hydroxylase and 17,20-lyase activity. At relatively high dosages (100 to 200 mg/day), it has demonstrated some effectiveness in the treatment of hirsutism. At these dosages, it frequently causes menstrual irregularity; therefore, it is often used in combination with an oral contraceptive. Flutamide is a nonsteroidal antiandrogen, which was originally used for the treatment of prostate diseases. It has been shown to have some beneficial effects in patients with hirsutism. The rare but potentially serious side effect of hepatotoxicity has probably restrained the widespread use of this medication for treatment of hirsutism.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Any balding females? I need advice with coping :(

       17 upvotes 10 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Opinions on Scalp fibrosis and DHT?

      in Research/Science  9 upvotes 3 years ago
      The conversation discusses the theory that scalp fibrosis contributes to male pattern baldness (MPB) by increasing DHT concentration, and mentions treatments like Minoxidil. The user seeks opinions on the theory and the effectiveness of scalp massages.

      community Does low HGH leading to hairloss?

      in Research/Science  11 upvotes 2 years ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    6 / 6 results